Medical Devices Global

Global Alzheimer's Blood Tests Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Global Alzheimer's Blood Tests Market Industry Trends and Forecast to 2034: Segmented by (Biomarker, Use, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Global · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $375.0 Mn Placeholder estimate
Estimate 2025 $468.8 Mn Placeholder estimate
Projected 2034 $3.49 Bn 645.1% Adds $3.02 Bn over 9 forecast years
CAGR 2025–2034 25.0% Faster than 96% of 193 Medical Devices markets here
Key players 5
  • Worldwide, the largest is US at $174.6 Mn.
  • Fastest growing: India at 27.9% a year.

Market size projection

Global

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$3.02 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Alzheimer's Blood Tests Market market size by year, Global
YearMarket sizeChange that yearSince 2025
2024 (estimate) $375.0 Mn — —
2025 (base) $468.8 Mn +$93.8 Mn —
2026 (forecast) $585.9 Mn +$117.2 Mn +25%
2027 (forecast) $732.4 Mn +$146.5 Mn +56.3%
2028 (forecast) $915.5 Mn +$183.1 Mn +95.3%
2029 (forecast) $1.14 Bn +$228.9 Mn +144.1%
2030 (forecast) $1.43 Bn +$286.1 Mn +205.2%
2031 (forecast) $1.79 Bn +$357.6 Mn +281.5%
2032 (forecast) $2.24 Bn +$447.0 Mn +376.8%
2033 (forecast) $2.79 Bn +$558.8 Mn +496%
2034 (forecast) $3.49 Bn +$698.5 Mn +645.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Global Alzheimer's Blood Tests Market Analysis at a glance
Market size, 2025$468.8 Mn placeholder estimate
Forecast, 2034$3.49 Bn placeholder estimate
Growth (CAGR), 2025–203425.0% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledBlood-Based Biomarkers for Alzheimer's Disease
SegmentsBiomarker, use and end user (see all)
Key playersC2N Diagnostics, Roche Diagnostics, Fujirebio, Quanterix, Quest Diagnostics (see all)
Regulator worldwideIMDRFSource: International Medical Device Regulators Forum. Checked 14 Nov 2026.
Active clinical trials136 worldwideSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Global Alzheimer's Blood Tests Market Analysis Executive Summary

Alzheimer's blood tests measure proteins such as p-tau and amyloid in blood to help diagnose Alzheimer's disease without a brain scan.

Key segments of the alzheimer's Blood Tests market include biomarker (p-Tau217, Amyloid Beta 42/40 and Neurofilament Light) and use (Diagnosis, Clinical Trial Screening and Monitoring).

Bar chart: Global Alzheimer's Blood Tests market size, 2024–2034, placeholder estimates. $375.0 Mn in 2024, $468.8 Mn in 2025 and $3.49 Bn in 2034, 25.0% CAGR.
Global Alzheimer's Blood Tests market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Global Alzheimer's Blood Tests Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the alzheimer's Blood Tests market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the alzheimer's Blood Tests market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the alzheimer's Blood Tests market.

Competitive Landscape for Alzheimer's Blood Tests Market in Global

The alzheimer's Blood Tests market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Alzheimer's Blood Tests Market in Global

Alzheimer's Blood Tests worldwide: rules, payment and research

There is no single global regulator; the International Medical Device Regulators Forum (IMDRF) helps national regulators align their device rules.⁠[1] WHO reports that 4.5 billion people were not fully covered by essential health services in 2021.⁠[2] ClinicalTrials.gov lists 136 studies on Alzheimer's Blood Tests that are recruiting, active or about to start worldwide.⁠[3]

[1] International Medical Device Regulators Forum. Checked 14 Nov 2026.

[2] World Health Organization, universal health coverage. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how alzheimer's Blood Tests products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Global.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Alzheimer's Blood Tests right now, from free public sources.

Clinical trials

136 active trials worldwide

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Roche 2 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Eli Lilly and Company 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Alzheimer's Blood Tests in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Alzheimer's Blood Tests market worldwide?
Placeholder estimate: about $468.8 Mn in 2025, rising to about $3.49 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Alzheimer's Blood Tests market worldwide growing?
Placeholder estimate: about 25.0% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Alzheimer's Blood Tests market report cover?
The report splits the market by biomarker (p-Tau217, Amyloid Beta 42/40, Neurofilament Light), use (Diagnosis, Clinical Trial Screening, Monitoring) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Alzheimer's Blood Tests market?
Key players include C2N Diagnostics, Roche Diagnostics, Fujirebio, Quanterix and Quest Diagnostics.
What is driving the Alzheimer's Blood Tests market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the alzheimer's Blood Tests market.
Who regulates Alzheimer's Blood Tests worldwide?
There is no single global regulator; the International Medical Device Regulators Forum (IMDRF) helps national regulators align their device rules. Source: International Medical Device Regulators Forum. Checked 14 Nov 2026.
How is healthcare paid for worldwide?
WHO reports that 4.5 billion people were not fully covered by essential health services in 2021. Source: World Health Organization, universal health coverage. Checked 14 Nov 2026.
How many clinical trials on Alzheimer's Blood Tests are running worldwide?
136 studies are recruiting, active or about to start worldwide, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.
How much research is published on Alzheimer's Blood Tests?
PubMed lists 504 papers on Alzheimer's Blood Tests added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Global

See all

Related on diagnostics and lab testing and alzheimer's

See the topic